Treatment delivery and prescribing medications for opioid use disorder among American Indian and Alaska Native adults during the height of the COVID-19 pandemic.
American Indian and Alaska Native (AI/AN) communities experienced a disproportionate increase in opioid-related poisonings during COVID-19. Availability of treatment, such as medications for opioid use disorder (MOUD) within AI/AN communities, is therefore imperative. We completed qualitative interviews with substance use disorder treatment providers providing services to AI/AN adults to assess the impact of COVID-19 related regulatory changes (e.g., medication dosing) and transitions in services (i.e., telemedicine) that aimed to enhance access to care. This project was supported by CTN-0118.
Related protocols: CTN-0118
Categories:
Alaska Natives, COVID-19, Native Americans / American Indians, Opioid use disorder, Pharmacological therapy
Authors :
McCluskey, M.; Hirchak, Katherine A.; Bajet, Kelsey; Richardson, Meenakshi; Brigman, M.; Lizzy, Karen; Shaffer, Racquel; Keyes, Beverly; Anderson Oliver, Karen; Kropp, Frankie; McDonell, Michael; Roll, John M.; Campbell, Aimee N. C.; Venner, Kamilla L.
Source :
Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, 2024